A case of cutaneous metastatic adenosquamous carcinoma of the cervix
Main Article Content
Keywords
case, cutaneous, metastatic, adenosquamous, carcinoma, cervix, cervical cancer, ulceronodular, skin metastases, skin metastasis
Abstract
Introduction:
Cutaneous metastasis of cervical carcinoma is very rare, with a reported incidence of .1 to 2%. The adenosquamous carcinoma subtype has been reported the least.3-5 We present a case report of ulceronodular cutaneous metastasis of adenosquamous carcinoma of the cervix.
Case Description:
A 50-year-old African American female with an eleven-year history of metastatic adenosquamous carcinoma of the cervix presented to the emergency department with an asymptomatic rash in her groin for one-month duration. On physical exam, there were hyperpigmented to violaceous papulonodules across the mons pubis and three ulcerated plaques of the left mons pubis. Punch biopsy was consistent with metastases of cervical adenosquamous carcinoma. No disease specific interventions were taken, and the patient passed away five weeks later.
Discussion:
Cervical cancer rarely metastasizes to the skin, with a reported incidence of .1 to 2%. Among the subtypes, cutaneous metastasis of cervical adenosquamous carcinoma has been reported the least. In a review of 1185 cases of cervical cancer, Imachi et al found that only 15 cases spread cutaneously, none of which were adenosquamous carcinoma.5 Cutaneous metastases of cervical carcinoma predict a poor prognosis, with an average length of survival of three months.6Our patient developed cutaneous metastases eleven years after diagnosis, which is to our knowledge the longest reported interval from initial diagnosis to development of cutaneous metastases. Although rare, it is important to recognize cutaneous metastases of adenosquamous carcinoma of the cervix as it predicts a poor prognosis and treatment has not been shown to improve outcomes.
References
2. Seamon LG, Java JJ, Monk BJ, et al. Impact of tumour histology on survival in advanced cervical carcinoma: an NRG Oncology/Gynaecologic Oncology Group Study. British Journal Of Cancer. 2017;118:162.
3. Reingold IM. Cutaneous metastases from internal carcinoma. Cancer. 1966;19(2):162-168.
4. Fumerton R, Afifi T, Martinka M, de Gannes G. Cutaneous metastases of cervical adenosquamous carcinoma. Journal of the American Academy of Dermatology. 2010;63(2):e48-e49.
5. Imachi M, Tsukamoto N, Kinoshita S, Nakano H. Skin Metastasis from Carcinoma of the Uterine Cervix. Gynecologic Oncology. 1993;48(3):349-354.
6. Agrawal A, Yau A, Magliocco A, Chu P. Cutaneous Metastatic Disease in Cervical Cancer: A Case Report. Journal of Obstetrics and Gynaecology Canada. 2010;32(5):467-472.
7. Chu P, Wu E, Weiss LM. Cytokeratin 7 and cytokeratin 20 expression in epithelial neoplasms: a survey of 435 cases. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc. 2000;13(9):962-972.
8. Wang TY, Chen BF, Yang YC, et al. Histologic and immunophenotypic classification of cervical carcinomas by expression of the p53 homologue p63: a study of 250 cases. Human pathology. 2001;32(5):479-486.
9. Chen C-H, Chao K-C, Wang P-H. Advanced Cervical Squamous Cell Carcinoma with Skin Metastasis. Taiwanese Journal of Obstetrics and Gynecology. 2007;46(3):264-266.
10. Farley JH, Hickey KW, Carlson JW, Rose GS, Kost ER, Harrison TA. Adenosquamous histology predicts a poor outcome for patients with advanced-stage, but not early-stage, cervical carcinoma. Cancer. 2003;97(9):2196-2202.
Article Sidebar
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
Creative Commons Attribution (CC BY): lets others distribute and copy the article, to create extracts, abstracts, and other revised versions, adaptations or derivative works of or from an article (such as a translation), to include in a collective work (such as an anthology), to text or data mine the article, even for commercial purposes, as long as they credit the author(s), do not represent the author as endorsing their adaptation of the article, and do not modify the article in such a way as to damage the author's honor or reputation.
Authors retain copyright in their work and license the publisher to publish the content. The publisher is the National Society for Cutaneous Medicine, with production and publishing support provided by OJS, Open Journal Systems,see https://pkp.sfu.
Prior to January 2022, authors transferred copyright to the National Society for Cutaneous Medicine. However, all articles are freely available to anyone in the world. There are no subscription fees, page charges, or article processing charges.